Trial intelligence / Profile preview

Adjuvanted hepatitis B vaccination in healthcare workers who did not respond to conventional vaccines

2016-004991-23Phase 3Completed

Sponsor
Hospital Universitario de Salamanca
Start
May 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of hepatitis B surface antigen + monophosphoryl lipid A in hepatitis B (HBV), sponsored by Hospital Universitario de Salamanca. Started May 2017; status: completed.

02

Drugs

hepatitis B surface antigen + monophosphoryl lipid A
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on 2016-004991-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004991-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call